CHARACTERIZATION OF MURINE AND HUMAN IG-D-RECEPTORS ON T

小鼠和人类 IG-D-受体在 T 上的表征

基本信息

  • 批准号:
    3453615
  • 负责人:
  • 金额:
    $ 11.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-02-01 至 1994-12-31
  • 项目状态:
    已结题

项目摘要

Previous observations have established the rapid upregulation by oligomeric or cross-linked, but not monomeric, IgD of receptors for IgD (IgD-R) on a large percentage of murine and human peripheral T cells and helper T cell clones. IgD-R on T cells are also induced by stimulation with anti-CD3, IL-2, IL-4, IFN-gamma, and alternate pathway stimulating agents, such as PMA + ionophore. Many of these reagents, except for IL-2 and alternate pathway stimulators, fail to upregulate IgD-R on T cells from aged mice. In view of the immunoaugmenting properties of IgD-R+ T cells in young, but not in aged mice, these IgD-R appear to stabilize/promote T-B cell interaction, particularly with B cells bearing cross-linked surface IgD. Murine and human helper T hybridoma cells also express IgD-R and release soluble binding factors for IgD (IgD-BF) into their supernatants under the influence of IL-2, IL-4 or crosslinked IgD. Murine IgD-R+ receptors are 40kD molecules that can be specifically precipitated by IgD-Sepharose. These molecules, as well as isolated human IgD-R will be purified and subjected to partial amino acid sequencing. The numbers of IgD-R per cell will be quantitated on normal T cells, IgD-treated T cells and T hybridoma cells. Antibodies to the human IgD-R/BF (LTB9) are available and antibodies to the murine IgD-R/BF are being evaluated for specificity. Cloning of the cDNA of the human and murine IgD-R/BF will be approached using available activated T-cell cDNA libraries. Additional studies will concern the fine specificity of both the murine and human IgD-R: In view of recent findings implicating N-glycans on IgD in its binding to the murine IgD-R, the functional role of these glycans will be investigated. Particular attention will be given to the role of carbohydrate determinants on human IgD in its binding to the human T cell IgD-R.
先前的观察已经确定了低聚物的快速上调

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ASHOK R AMIN其他文献

ASHOK R AMIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ASHOK R AMIN', 18)}}的其他基金

Tissue Bank for Surgical Samples & Blood Cells from Patients with Osteoarthritis
手术样本组织库
  • 批准号:
    6974310
  • 财政年份:
    2004
  • 资助金额:
    $ 11.67万
  • 项目类别:
MURINE AND HUMAN IG-D-RECEPTORS
鼠类和人类 IG-D-受体
  • 批准号:
    2051568
  • 财政年份:
    1992
  • 资助金额:
    $ 11.67万
  • 项目类别:
CHARACTERIZATION OF MURINE AND HUMAN IG-D-RECEPTORS ON T
小鼠和人类 IG-D-受体在 T 上的表征
  • 批准号:
    3453614
  • 财政年份:
    1992
  • 资助金额:
    $ 11.67万
  • 项目类别:

相似海外基金

Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
  • 批准号:
    23H02361
  • 财政年份:
    2023
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : GNT1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : 1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9300976
  • 财政年份:
    2015
  • 资助金额:
    $ 11.67万
  • 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9920805
  • 财政年份:
    2015
  • 资助金额:
    $ 11.67万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8900121
  • 财政年份:
    2012
  • 资助金额:
    $ 11.67万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8225814
  • 财政年份:
    2012
  • 资助金额:
    $ 11.67万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8699511
  • 财政年份:
    2012
  • 资助金额:
    $ 11.67万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8525355
  • 财政年份:
    2012
  • 资助金额:
    $ 11.67万
  • 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
  • 批准号:
    9115537
  • 财政年份:
    1991
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了